SuperworthEntrada Therapeutics shares outstanding TRDA
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 42.2M
- On a year earlier
- +2.1%
- more shares
Entrada Therapeutics had 42.2M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 2.1% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 41.6M | −4% |
| FY2024 | 43.2M | +30% |
| FY2023 | 33.4M | +6% |
| FY2022 | 31.4M | +2548% |
| FY2020 | 1.2M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 42.2M | +2% | |
| Q1 FY26 | 41.8M | +2% | |
| Q4 FY25 | 41.6M | −4% | |
| Q3 FY25 | 41.5M | +2% | |
| Q2 FY25 | 41.3M | +16% | |
| Q1 FY25 | 41.1M | +18% | |
| Q4 FY24 | 43.2M | +30% | |
| Q3 FY24 | 40.6M | +17% | |
| Q2 FY24 | 35.5M | +7% | |
| Q1 FY24 | 34.8M | +7% | |
| Q4 FY23 | 33.4M | +6% | |
| Q3 FY23 | 34.8M | +11% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Entrada Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.